HD-OPM Archive
Hashtags

#vitaminb3

28 posts

Niacin can cut Lp(a) (one member saw 40% with 1500 mg) but has no outcome proof

Jan 19, 2024 · Louis Nervegna ♥ 15 · 💬 37 Lp(a)

Louis explains niacin can be effective at lowering Lp(a) and is still used by some cardiologists, with one group member reporting a 40% Lp(a) drop on 1500 mg. He gives tips for reducing the harmless flush and explains sustained-release formulations. He warns niacin has not been shown in large RCTs to reduce heart attacks, strokes or mortality, and two large trials found no added benefit on top of high-dose statins but more side effects.

Blood NAD levels do not fall with age, so commercial NAD blood tests are useless

Oct 24, 2026 · Louis Nervegna ♥ 15 · 💬 5 Aging & longevity

A new Nature Metabolism study found whole-blood NAD+ levels stay stable with age across seven independent human cohorts. Louis explains blood NAD mainly reflects recent vitamin B3 intake, so commercial NAD blood tests are not meaningful, while tissue NAD levels may matter but cannot be commercially measured. There is still no convincing clinical evidence NR or NMN supplements slow human aging.

HDL and ApoA-I raising therapies repeatedly failed, so HDL is probably not directly causal

Mar 11, 2024 · Louis Nervegna ♥ 6 · 💬 9 ↩ 22 LDL, ApoB & lipid panel

Louis reviews why HDL or ApoA-I is probably not causal for heart disease. CETP inhibitor trials failed (ILLUMINATE with torcetrapib was stopped for harm; dal-OUTCOMES with dalcetrapib and ACCELERATE with evacetrapib showed no benefit), as did fibrate and niacin trials and CSL112 infusions, and Mendelian randomization agrees. He proposes HDL and ApoA-I mainly act as a proxy for insulin sensitivity, which is the real causal factor.

Glycation and AGEs in cardiovascular aging: Kapahi on methylglyoxal and the GLYLO suppleme

Dec 18, 2023 · Louis Nervegna ♥ 7 · 💬 9 ↩ 1 Aging & longevity

Louis says he underestimated glycation and AGEs in aging after Pankaj Kapahi's work at the Buck Institute. Kapahi's post explains methylglyoxal as a reactive glycolysis byproduct that drives AGEs and aging, and describes GLYLO, a combination of lipoic acid, nicotinamide, piperine, pyridoxine and thiamine that lowered methylglyoxal and AGEs and extended mouse lifespan even when started late. Louis says Kapahi plans a paper showing it reduces arterial stiffening. Evidence is preclinical and the product is commercial.

Case: carotid plaque regression with salmon, niacin and low-dose rosuvastatin

Dec 23, 2023 · Louis Nervegna ♥ 13 · 💬 3 Plaque, CAC & CT angiography

Louis shares a video by Dr. Ford Brewer describing his own plaque reversal. He ate salmon daily, added niacin and low-dose rosuvastatin and switched from an ARB to an ACE inhibitor, with a major decrease in carotid plaque volume and CIMT arterial age falling from 72 to 52. It is a single self-reported case in a video from a clinic that also sells services and supplements.

Nicotinic acid (vitamin B3) may prevent or treat glaucoma, possibly via NAD

Dec 10, 2023 · Louis Nervegna ♥ 12 · 💬 2 ↩ 2 Supplements & vitamins

Louis notes growing evidence that nicotinic acid, the niacin form used to lower cholesterol, may prevent or treat glaucoma, a disease with no effective treatment that causes irreversible blindness. The mechanism likely involves NAD. Most studies used nicotinic acid, so it is unclear how nicotinamide, NR or NMN compare. This is an eye-health tangent, supported by a video.